Indianapolis Business Journal

JUNE 22-28, 2015

After years of pipeline failures, Eli Lilly and Co. is on a bit of a hot streak. J.K. Wall reports on some needed successes in clinical trials for experimental drugs, and how Lilly’s strategy has changed. Also in this week’s issue, Scott Olson has the latest on the fate of the former General Motors stamping plant site near downtown, dealt a blow by the cancelled deal for a criminal justice center. And the whole staff teams up for our annual “Indiana 100” publication, a look at the state’s top companies.

Front PageBack to Top

Top StoriesBack to Top

OpinionBack to Top

SCHMIDT: Yes, Indy has been outscored by Detroit

It’s shocking that Indianapolis’ Walk Score wasn’t higher when we just heard so many positive comments from Final Four visitors about how easy it was to walk from hotels to restaurants, bars and Lucas Oil Stadium.

Read More

Vision Fleet is victim of political tussle

My company is stuck in the middle of a dispute that threatens not just one municipal fleet modernization program, but the reputation of a city that wants to develop innovative solutions that can be replicated elsewhere.

Read More

In BriefBack to Top